Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.59 USD | +2.49% | -2.89% | -9.49% |
05-10 | Wedbush Trims Xenon Pharmaceuticals' Price Target to $50 From $51, Maintains Outperform Rating | MT |
05-09 | Xenon Pharmaceuticals Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.49% | 3.06B | |
+7.04% | 111B | |
+10.35% | 106B | |
-12.59% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.43% | 16.81B | |
+38.91% | 12.54B | |
-24.90% | 8.09B |
- Stock Market
- Equities
- XENE Stock
- News Xenon Pharmaceuticals Inc.
- Guggenheim Adjusts Price Target on Xenon Pharmaceuticals to $49 From $53, Maintains Buy Rating